Artificial intelligence biotech company Owkin announced Friday that its rapid AI diagnostic solutions for breast cancer and colorectal cancer have been approved for use in Europe. The tests are the first approved diagnostics created by Owkin, which has offices in New York City and Paris. One of the solutions is RlapsRisk BC, which uses AI to predict if a breast […]